Thryve Peptides
Tesamorelin (10mg)
Tesamorelin (10mg)
Couldn't load pickup availability
Tesamorelin 10MG
Precision-engineered peptide for growth hormone–releasing research applications.
- Tesamorelin is a stabilized analog of growth hormone–releasing hormone (GHRH 1–44) designed for controlled laboratory studies.
- Explored in research for its effects on growth hormone regulation, IGF-1 signaling, and metabolic modulation.
- Each batch independently verified for purity, identity, and sequence integrity by Vanguard Laboratory.
For laboratory research use only. Not for human consumption.
Scientific Evidence
Tesamorelin (TH9507) is a synthetic peptide analog of human growth hormone–releasing factor (GHRH). It has been investigated in laboratory and clinical settings for its role in modulating pituitary GH secretion and IGF-1 release (PubMed 20375194).
Studies show Tesamorelin binds to GHRH receptors in pituitary cells, stimulating endogenous growth hormone release in a pulsatile manner and influencing lipid metabolism under experimental conditions (PubMed 18550364).
Additional research explores Tesamorelin’s potential metabolic and endocrine applications in pre-clinical environments (PubMed 23167810).
Regulatory Status: Tesamorelin is not FDA-approved for human or veterinary use. This compound is provided strictly for laboratory research applications.
